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Abstract 
Background: Novel indoor residual spraying (IRS) and long-lasting insecticidal net (LLIN) products aimed at improv-
ing the control of pyrethroid-resistant malaria vectors have to be evaluated in Phase II semi-field experimental 
studies against highly pyrethroid-resistant mosquitoes. To better understand their performance it is necessary to fully 
characterize the species composition, resistance status and resistance mechanisms of the vector populations in the 
experimental hut sites.
Methods: Bioassays were performed to assess phenotypic insecticide resistance in the malaria vector population 
at a newly constructed experimental hut site in Cové, a rice growing area in southern Benin, being used for WHOPES 
Phase II evaluation of newly developed LLIN and IRS products. The efficacy of standard WHOPES-approved pyrethroid 
LLIN and IRS products was also assessed in the experimental huts. Diagnostic genotyping techniques and microar-
ray studies were performed to investigate the genetic basis of pyrethroid resistance in the Cové Anopheles gambiae 
population.
Results: The vector population at the Cové experimental hut site consisted of a mixture of Anopheles coluzzii and 
An. gambiae s.s. with the latter occurring at lower frequencies (23 %) and only in samples collected in the dry season. 
There was a high prevalence of resistance to pyrethroids and DDT (>90 % bioassay survival) with pyrethroid resistance 
intensity reaching 200-fold compared to the laboratory susceptible An. gambiae Kisumu strain. Standard WHOPES-
approved pyrethroid IRS and LLIN products were ineffective in the experimental huts against this vector population 
(8–29 % mortality). The L1014F allele frequency was 89 %. CYP6P3, a cytochrome P450 validated as an efficient metab-
olizer of pyrethroids, was over-expressed.
Conclusion: Characterizing pyrethroid resistance at Phase II field sites is crucial to the accurate interpretation of the 
performance of novel vector control products. The strong levels of pyrethroid resistance at the Cové experimental hut 
station make it a suitable site for Phase II experimental hut evaluations of novel vector control products, which aim for 
improved efficacy against pyrethroid-resistant malaria vectors to WHOPES standards. The resistance genes identified 
can be used as markers for further studies investigating the resistance management potential of novel mixture LLIN 
and IRS products tested at the site.
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Background
Malaria vector control and prevention today largely 
depends on the use of insecticides applied as indoor 
residual spray (IRS) or long-lasting insecticidal nets 
(LLINs). Both interventions are effective [1, 2] and have 
contributed immensely to reducing the burden of malaria 
in recent years [3]. Nevertheless, the rapid development 
and spread of insecticide resistance to the limited classes 
of insecticides approved for vector control poses a major 
threat to the gains so far achieved in malaria control [4]. 
The need for new insecticide products that can circum-
vent existing mechanisms of resistance to current insecti-
cides has become critical.
There is currently concerted effort from the interna-
tional vector control community towards the develop-
ment of new public health insecticides. The present 
portfolio of the Innovative Vector Control Consortium 
(IVCC) for example, is designed to produce three entirely 
new classes of insecticides by 2023 with no cross-resist-
ance to existing classes of insecticides [5]. The IVCC has 
set up several projects and some novel IRS and LLIN 
products have been taken to evaluation phase. The World 
Health Organization (WHO) through its pesticide evalu-
ation scheme (WHOPES) has set criteria that such prod-
ucts must meet to obtain recommendation for large-scale 
use against malaria vectors. WHOPES guidelines require 
that these products be evaluated in Phase I laboratory, 
Phase II semi-field experimental hut studies and in Phase 
III randomized controlled trials in households or village 
clusters [6, 7].
Experimental huts are a good simulation of human-
occupied houses which allow the performance of indoor 
vector control interventions/products to be measured 
in terms of their ability to kill mosquitoes, prevent feed-
ing and deter mosquitoes from entering a home. Several 
experimental hut stations have been constructed across 
sub-Saharan Africa and used for evaluating various 
indoor vector control products/tools following WHOPES 
guidelines [8–13]. However, the resistance profile of the 
local vector populations in some of these studies was 
not fully characterized at the time of evaluation, mak-
ing interpretation of results complex [14]. Considering 
the movement towards the evaluation of a new genera-
tion of vector control products that are expected to show 
improved efficacy against insecticide-resistant mos-
quitoes in order to attain WHO recommendation for 
large-scale use in pyrethroid resistant areas, it becomes 
imperative that the vector populations at experimental 
hut stations used for such evaluations are highly resist-
ant and the profile of resistance and vector species is fully 
characterized and understood at the time of evaluation. 
In addition, because insecticide resistance tends to vary 
from one locality to another usually over very short dis-
tances, the local vector resistance profile reported for 
such Phase II evaluations has to be specific for the vicin-
ity of the experimental hut station where the study was 
conducted. Furthermore, the new guidelines for substan-
tiating efficacy claims of novel LLINs in areas of high 
resistance recently published by the Vector Control Advi-
sory Group (VCAG) [15] specifies criteria that the vector 
populations in hut sites used for Phase II evaluations of 
such novel products should meet; the vector population 
should be well characterized and should have a pyre-
throid resistance ratio of at least ten-fold compared to a 
susceptible laboratory strain.
The current study was designed to fully characterize 
insecticide resistance in the Anopheles gambiae sl vec-
tor population from an experimental hut station in Cové, 
Benin, a newly constructed site belonging to the Pan 
African Malaria Vector Research Consortium (PAM-
VERC) collaborative site between the London School 
of Hygiene and Tropical Medicine (LSHTM) and Cen-
tre de Recherches Entomologique de Cotonou (CREC) 
in parallel with a series of Phase II evaluations of novel 
IRS and LLIN products to WHOPES standards. Stud-
ies were also performed to assess year-round hut-entry 
rates in the Cové site. The efficacy of current WHOPES-
approved pyrethroid IRS and LLINs was assessed in the 
experimental huts. The implications of the findings for 
the evaluation of the novel vector control tools aimed at 
improving the control of insecticide-resistant vector pop-
ulations is discussed.
Methods
Cové site and experimental huts
The Cové Phase II experimental hut station is situ-
ated at the centre of a huge rice field in the city of Cové 
(7o14′N2o18′E) located 159  km from Cotonou, the eco-
nomic capital of Benin (Fig. 1). The rice paddies provide 
extensive breeding sites for An. gambiae s.l. throughout 
the year. The rainy season extends from March to Sep-
tember and the dry season from October to February. 
Irrigated rice farming is done twice every year at the 
hut station, the first from March to May and the second 
from October to January. Seventeen experimental huts of 
the typical West African design described in WHOPES 
Keywords: Insecticide resistance, Experimental huts, Cové, Vector control product evaluation, Anopheles gambiae sl, 
Long-lasting insecticidal nets, Indoor residual spraying
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guidelines [6] have been constructed at this site by the 
PAMVERC collaborative unit between LSHTM and 
CREC.
To assess year-round variation in mosquito density and 
hut-entry rates in the experimental huts at Cové, consent-
ing human volunteers slept under an untreated net in the 
huts and mosquitoes were collected daily over 12 months 
and brought to the laboratory for identification.
WHO susceptibility bioassays
WHO susceptibility tests to assess the prevalence of 
resistance were performed using papers obtained from 
Universiti Sains Malaysia, impregnated with a range of 
insecticides from the four approved classes for vector 
control: namely, 0.75  % permethrin, 4  % DDT, 0.05  % 
deltamethrin, 0.1  % bendiocarb, 5  % malathion, and 
4  % fenithrothion. Adult female mosquitoes 2–3  days 
old, which emerged from larvae collected from breed-
ing sites next to the experimental huts, were exposed 
for 1  h to the insecticide-treated papers and mortality 
was recorded 24 h later. Approximately 100 mosquitoes 
(four replicates of 25 mosquitoes) were used per test and 
the average mortality was calculated. Control mosqui-
toes were exposed to untreated papers. Resistant females 
which remained alive after 24 h were kept for one more 
day until they were 3–4 days old, after which they were 
preserved submerged in RNA later for genotyping, target 
site resistance and microarray studies.
Resistance intensity dose–response bioassay
To determine the intensity of resistance to pyrethroids 
in the wild An. gambiae Cové strain, mosquitoes that 
emerged from larvae collected from breeding sites at 
the experimental hut station were tested in CDC bottle 
bioassays treated with a range of doses of alphacyperme-
thrin from 0.05 to 5 µg. Comparison was made with the 
laboratory-susceptible An. gambiae Kisumu strain tested 
with a dose range of 0.0005–0.05 µg. Alphacypermethrin 
was chosen for this study because it was one of the main 
pyrethroid insecticides used as a positive control in the 
parallel hut evaluations. A total of 100 mosquitoes were 
exposed for 1  h at each concentration and deaths were 
scored 24 h later. Log-dosage mortality curves were gen-
erated using probit analysis and estimates of the dose 
required to kill 50 % (LD50) of each strain and the resist-
ance ratios relative to the susceptible laboratory strain 
were generated (PoloPlus version 1.0).
Synergist bioassays
The effect of the insecticide synergist piperonyl butox-
ide (PBO), the primary action of which is to inhibit P450 
mono-oxygenase enzymes, was evaluated in CDC bot-
tle bioassays. One-hundred and fifty-two to five day old 
adult females were exposed (in batches of 25 mosquitoes) 
for 30  min in bottles treated with permethrin (21.5  µg/
bottle) either alone or after 1  h pre-exposure to PBO 
(400  µg/bottle). Mosquitoes were also exposed to PBO 
alone. Control bottles were treated with acetone alone. 
The laboratory-susceptible Kisumu strain was also tested 
in bottles treated with permethrin alone for comparison. 
Mortality was recorded after 24 h.
Efficacy of standard pyrethroid LLIN and IRS 
in experimental huts in Cové, Benin
To demonstrate the impact of pyrethroid resistance 
in Cové on the performance of standard WHOPES-
approved pyrethroid LLINs and IRS products, hut data 
with pyrethroid treatments from four experimental hut 
trials that were performed in the Cové experimental huts 
station in parallel to this study were combined. These 
trials evaluated different novel IRS and LLIN products 
in comparison with the currently approved pyrethroid 





Fig. 1 Map of Cové, Benin
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from the individual evaluation studies are being reported 
separately but for the current study, the mortality rates 
for mosquitoes entering huts treated with the WHOPES-
approved pyrethroid LLINs and IRS were analysed and 
comparison made with an untreated control net. The fol-
lowing five treatments were included:
1. Untreated control net
2. Olyset Net (permethrin-incorporated LLIN)
3. Interceptor 1 (alphacypermethrin-coated LLIN)
4. Deltamethrin IRS applied at 25 mg/sq m
5. Alphacypermethrin IRS applied at 25 mg/sq m
During the trials, consenting human volunteers slept 
in the huts from dusk to dawn to attract mosquitoes. 
Mosquitoes were collected in the morning and brought 
to the laboratory for identification and scoring of mor-
tality, blood feeding rate and exophily. The nets were 
rotated between huts to account for hut attractiveness to 
mosquitoes while the sleepers were rotated on successive 
nights to reduce any bias due to individual attractiveness 
to mosquitoes in accordance with a Latin square design.
Ethical considerations
Chemoprophylaxis was provided to volunteer sleepers 
prior to the hut studies. Approval was obtained from the 
ethics review boards of the London School of Hygiene 
and Tropical Medicine and the Ministry of Health in 
Benin.
Species identification and target site resistance
To identify vector species and target site resistance in 
Cové, DNA was extracted from a pair of legs taken from 
each female mosquito tested in the WHO susceptibility 
bioassays, and also from a set of unexposed mosquitoes 
(N = 89) collected from the Cové hut site at the begin-
ning of the previous dry season (September–October 
2014) for comparison between seasons. The legs were 
transferred to 96-well plates and extraction was done 
using a buffer-based boiling method. Species identifica-
tion was conducted on each DNA sample using stand-
ard PCR techniques [16, 17]. TaqMan assays were used 
to characterize each sample for genotypes at three loci in 
the voltage-gated, sodium channel, target site (L1014F, 
L1015S and N1575Y) [18, 19] which confer resistance 
to DDT and pyrethroids, and also for the ace-1 G119S 
resistance mutation in acetylcholinesterase, the target 
site of organophosphates and carbamates [20].
Microarrays
Total RNA was extracted from batches of ten mosquitoes 
that survived exposure to either deltamethrin or perme-
thrin using the Ambion RNA extraction Kit. RNA quality 
and quantity was assessed using a NanoDrop spectro-
photometer (Thermo Fisher Scientific) and a 2100 Bio-
analyzer (Agilent Technologies) before further use. Three 
biological replicate extractions of total RNA from batches 
of ten mosquitoes for each treatment population were 
labelled and hybridized to the An. gambiae 15  k whole 
genome microarray using previously described proto-
cols [21]. Expression profiles of females from pyrethroid-
susceptible NGuosso and Kisumu strains, unexposed to 
insecticides, were compared to those of the permethrin 
and deltamethrin-selected Cové females using an inter-
woven loop design (Fig.  2). The design is optimized for 
two microarray slides (16 arrays) to maximize direct con-
nections of primary interest (resistant vs susceptible).
Results
Monthly hut‑entry rates
The average numbers of mosquitoes entering the experi-
mental huts in Cové from December 2013 to Novem-
ber 2014 are presented in Fig. 3. The entry rates did not 
coincide with the rainy seasons; average numbers enter-
ing were highest during the drier months of the year 
(November to February) when rainfall is lowest in Cové. 
Peaks in monthly hut-entry rates occurred 2 months into 
Fig. 2 Interwoven loop design with three pools each of deltame-
thrin- (Delta) and permethrin-selected (Perm) samples from Cové, 
Benin, and one pool each from fully pyrethroid-susceptible colony 
samples (NGuosso and Kisumu). The outer loop connections run 
clockwise, directionality of inner connections is indicated by arrows: 
1:2 indicates the dye label applied to the pool at the start and end 
of the connection, respectively. The R program MAANOVA [34] was 
used to analyse the interwoven loop data using previously described 
custom R-scripts [21]. No outlying quality microarrays were detected. 
Analysis used a threshold for gene discovery, which relied on consist-
ency of a liberal P value threshold (P < 0.05), coupled with consist-
ency in over-expression and a fold-change threshold of >2 across all 
deltamethrin and permethrin pools vs both susceptible pools
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the first and second rice planting (49/hut/night in April 
and 144/hut/night in December, respectively) thus show-
ing synchrony with rice planting seasons in Cové. The 
lowest entry rate was recorded between July and Septem-
ber (3.5–6.5/hut/night).
WHO susceptibility bioassays
The mortality rates of the wild Cové strain exposed to 
diagnostic doses of insecticides in WHO susceptibility 
bioassays are presented in Fig.  4. Mortality in the con-
trol was 4  %. Mortality with the organochlorine DDT 
and with pyrethroids was less than 15 % indicating a high 
prevalence of resistance to both classes of insecticide. 
Bendiocarb, malathion and fenitrothion induced 100  % 
mortality demonstrating full susceptibility to organo-
phosphates and carbamates.
Resistance intensity bioassays
The results on dose–response studies comparing the 
Cové and Kisumu strain are presented in Table  1. The 
LD50 values were 0.0004 µg/ml for Kisumu and 0.083 µg/
ml for the Cové strain. This resulted in a resistance 
ratio (RR) of 200-fold in the wild Cové compared to the 
Kisumu strain.
PBO synergist bioassays
Mortality in CDC bottles treated with permethrin alone 
was 100  % with the Kisumu strain but only 32  % with 
the Cové population (Fig.  5). Pre-exposure of the Cové 
population to PBO resulted in a significant increase in 
mortality to 50  % (P  <  0.05), suggesting at least some 
involvement of P450 detoxification enzymes in perme-
thrin resistance in this vector population.
Efficacy of standard pyrethroid LLIN and IRS 
in experimental huts in Cové, Benin
Results of the efficacy of standard pyrethroid LLINs and 
IRS in experimental huts in Cové, Benin are presented 
in Fig.  6. Mortality with the control net was 5  %. Mor-
tality did not exceed 30  % with any of the pyrethroid 
treatments tested. The pyrethroid LLINs induced higher 
mortality rates (29  % with Olyset Net and 22  % with 
Interceptor 1) than the pyrethroid IRS treatments (8  % 
with deltamethrin and 12 % with alphacypermethrin).
Species identification
Species identification PCR results revealed that the vec-
tor population was 100 % An. gambiae (N = 187). SINE 
PCR results showed that the population consisted of a 
mixture of the Anopheles coluzzii and An. gambiae s.s., 
the proportions of which showed seasonal variation. 
Twenty-three per cent of 89 samples collected in the dry 
season were An. gambiae s.s. while no An. gambiae s.s. 
was found in samples collected during the rainy season 
(N = 169); Chi-sq = 29.2, 1 df, P = 6 × 10−8.
Target site resistance alleles
Overall, 1014F allele frequency in the Cové population 
was 89  % (n =  247), and this did not vary significantly 












December January February March April May June July August September October November
Av. Number of mosquitoes
Av. Rainfall (mm)
Start of 1st cropping 
season 
Start of 2nd 
cropping season 
Fig. 3 Monthly average night catch of Anopheles gambiae in untreated experimental huts in Cové, Benin
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(P  >  0.05) (Table  2). No 1014S alleles were found, and 
only one heterozygote for the N1575Y mutation was 
identified. The ace-1 119S allele was also very rare.
Microarray results
Genes meeting the thresholds for significant over-expres-
sion in the microarray studies are presented in Fig. 7. A 
total of 113 probes covering 83 genes were significantly 
over-expressed in the Cové deltamethrin- and perme-
thrin-resistant pools relative to the Kisumu and NGousso 
pools, and several of these are known detoxification 
genes. Using equivalent criteria for under-expression, 
16 probes covering 12 genes were detected. The major-
ity of the significantly differentially expressed genes do 
not have known roles in insecticide resistance, including 
those with highest statistical confidence and fold-change 
(the full table of results is given in Additional file 1). Of 
the detoxification genes, highlighted in Fig.  7, there are 
two cytochrome P450s, CYP6P3 and CYP9K1, a glu-
tathione S-transferase GSTs1, a thioredoxin gene, TRX2, 
and superoxide-dismutase, SOD1. The best known of 
these genes in terms of resistance association, CYP6P3, 
is over-expressed in Cové at an average level of approxi-
mately four times compared to the susceptible strains.
Discussion
The current study was designed to provide an in-depth 
characterization of the genotype and resistance profile 
of An. gambiae s.l. at a newly constructed experimen-
tal hut station in Cové, Benin, being used for WHOPES 
Phase II evaluation of novel IRS and LLIN products that 
are expected to show improved performance against pyre-
throid-resistant mosquito vectors and potentially man-
age resistance. Characterizing the vector population in an 
experimental hut site is crucial to the accurate interpreta-
tion of results obtained in the evaluation of such products.
For any given experimental hut study, a minimum aver-
age hut-entry rate is usually required for the study to have 
enough statistical power to demonstrate the expected 
impact [22]. As expected of most rice growing areas in 
West Africa, the Cové experimental hut site is charac-
terized by very high mosquito vector densities, which 
resulted in high hut-entry rates, making the site suitable 
for most Phase II product evaluation studies. Neverthe-
less, the results also showed seasonality in vector den-
sity linked to the rice cropping season with the lowest 








Fig. 4 Mortality (%) of wild Anopheles gambiae sl from the experimental hut station Cové, Benin exposed to diagnostic doses of insecticides in 
WHO cylinder bioassays. Error bars represent 95 % confidence intervals
Table 1 Intensity of  pyrethroid (alpha-cypermethrin) 
resistance in Anopheles gambiae sl from experimental hut 
station in Cové, Benin
Lethal doses (LD) are expressed in µg/ml




RR 50 (95 % CI)





Cové 1.3 (0.35) 0.083 
(0.04–0.1)
1.49 (0.8–4.4) 200 (120.3–
315.8)
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hut entry recorded in the months of June–September, a 
period during which no rice growing activity is ongoing 
and rice paddies are dry. Assuming that the rice cropping 
seasons in Cové remain unchanged, plans have been 
made to exclude this period where possible when plan-


















Fig. 5 Mortality (%) of wild Anopheles gambiae sl from Phase II experimental hut station Cové, Benin exposed to permethrin in CDC bottle bioassays 

















Fig. 6 Mortality (%) of pyrethroid resistance Anopheles gambiae sl in experimental huts in Cové, Benin treated with standard pyrethroid LLINs and 
IRS products. Error bars represent 95 % confidence intervals
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The resistance bioassays demonstrated very high lev-
els of phenotypic resistance to pyrethroids and DDT in 
the Cové wild An. gambiae s.l. population, revealing a 
resistance ratio of 20-fold (compared to a susceptible 
laboratory strain) which far exceeds the minimum of ten-
fold set by the VCAG for the evaluation of new LLINs 
with efficacy claims against highly pyrethroid-resistant 
mosquitoes [15]. This was confirmed by the low mor-
tality rates (<30  %) achieved with standard WHOPES-
approved pyrethroid LLINs and IRS in the experimental 
huts in Cové. Mortality rates of >80  % with pyrethroid 
IRS and insecticide-treated nets have been reported in 
earlier experimental hut studies in a previously pyre-
throid-susceptible area in Benin [23]. The findings here 
constitute further evidence of the poor performance of 
current pyrethroid IRS and LLIN products when con-
fronted with highly pyrethroid-resistant vector popula-
tions [9, 14, 23, 24]. The novel IRS and LLIN products 
being tested in the experimental huts in Cové involve 
non-pyrethroid classes of insecticide with new modes of 
action to which there are currently no records of resist-
ance in malaria vectors; hence, improved mortality rates 
are expected.
The genotyping results revealed that the vector popu-
lation in the Cové experimental hut station is composed 
of a mixture of An. coluzzii and An. gambiae s.s. with 
their relative abundance varying through the course of 
the year. While all samples genotyped from the March 
cropping season (start of the rainy season in 2014) were 
An. coluzzi, An. gambiae s.s. was found in a smaller pro-
portion (23 %) only in samples that were collected at the 
start of the October annual rice cropping season in the 
Cové site (start of the dry season in 2013). Seasonal vari-
ation in these two sub-species of An. gambiae has been 
reported in several areas in West Africa [25, 26]. Unlike 
the An. coluzzi which is well adapted to rice paddies in 
Table 2 Frequency of  target site resistance alleles 
in  Anopheles gambiae sl from  experimental hut station 
in Cové, Benin
RR homozygous resistant, RS heterozygous, SS homozygous susceptible
Resistance  
gene




L1014F 200 41 6 247 89
Ace-1 119S 0 2 178 180 0.6

























log2 overexpression level (fold change)
Fig. 7 Genes significantly over-expressed (relative to susceptibles) in pyrethroid-resistant Anopheles gambiae sl from experimental hut station in 
Cové, Benin
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West Africa, An. gambiae s.s. tends to occupy transitory 
man-made breeding sites, such as pits, ponds and pud-
dles which are more likely to exist in the dry season in 
Cové. Nevertheless, because both species contribute 
similarly to disease transmission and are anthropophilic 
and endophilic [26], they can be equally targeted by the 
various novel IRS and LLIN products being evaluated in 
the experimental huts in Cové. Further studies are under-
way to investigate the extent of the variation in both vec-
tor sub-species in Cové through the course of the year, 
in relation to other human activities at the site and to 
assess the impact it may have on phenotypic resistance to 
pyrethroids.
The resistance genotyping studies suggests that the 
pyrethroid resistance encountered in the Cové vector 
population could be partly attributable to high frequen-
cies of the 1014F kdr allele (0.89 allele frequency), with 
the 1014S mutation absent and the 1575Y allele very rare. 
The latter should be monitored however because it can 
effectively double the resistance conferred by 1014F alone 
[19]. Ace-1 119S was also very rare, which likely explains 
the lack of any carbamate or organophosphate resistance. 
However, again this requires monitoring because it is 
strongly diagnostic of resistance to each insecticide class 
[27] and can confer very high resistance in combination 
with P450 metabolic enzymes [28]. Indeed, some vector 
populations in West Africa with high frequencies of pyre-
throid resistance mutations and the ace-1 119S mutation 
are resistant to all current classes of insecticides [29]. 
The PBO synergism data suggested a moderate impact of 
P450 enzymes in resistance, which was confirmed by the 
microarray study that identified two P450 genes as over-
expressed in pyrethroid-selected An. coluzzi in Cové. Of 
these, CYP6P3 has been previously validated as a metab-
olizer of class I and II pyrethroids [30] and bendiocarb to 
a lesser extent [28]. CYP6P3 has been reported as over-
expressed in pyrethroid-resistant field populations of 
An. gambiae s.l. from Dodowa in Ghana [31], Akron and 
Gbejromede in Benin, Orugun in Nigeria [32], and Tias-
sale in Côte d’Ivoire [28] and is thus operationally con-
sidered a key diagnostic marker of pyrethroid resistance. 
Further studies will be needed to investigate the other 
genes which were over-expressed in the microarray study 
for their roles in conferring pyrethroid resistance.
Conclusion
In addition to improving the control of pyrethroid-resist-
ant malaria vectors, the novel LLIN and IRS products 
evaluated at the Cové site are expected to also manage 
pyrethroid resistance since they are treated with insecti-
cide mixtures [4, 33]. To investigate this, surviving mos-
quitoes from the different experimental hut treatments 
have been preserved in RNAlater for further studies 
comparing their capacity to prevent selection on insec-
ticide resistance genes. Based on the microarray results 
obtained in the present study, CYP6P3 can be considered 
a suitable candidate gene for investigating selection of 
metabolic resistance to pyrethroids in follow-up quanti-
tative real time PCR studies.
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